Findings can lead to gut replacement therapy in people with intestinal deficiencies
Working with gut stem cells from humans and mice, scientists from the Johns Hopkins Children’s Center and the University of Pittsburgh have successfully grown healthy intestine atop a 3-D scaffold made of a substance used in surgical sutures.
In a further step that takes their work well beyond proof of concept, researchers report their laboratory-created intestine successfully regenerated gut tissue in the colons of dogs with missing gut lining.
The experiments, described ahead of print in the journal Regenerative Medicine, bring researchers closer to creating an implantable intestine as replacement therapy for a range of devastating disorders – including infections, cancer and trauma – that result in loss or death of gut tissue. Chief among them is a condition that affects 12 percent of premature newborns, called necrotizing enterocolitis (NEC), which is marked by the rapid death of intestinal cells and permanent loss of intestinal tissue.
The tube-shaped scaffold, designed several years ago in collaboration with Cornell University researchers and composed of biodegradable material similar to that used in surgical sutures, was a big first step on the quest to develop an implantable replacement intestine. But the new work pushes that effort further because it shows how stem cells, when mixed with immune and connective tissue cells, can grow into normal gut tissue around the scaffold and function inside a living mammal.
Researchers caution that a fully functioning replacement intestine for humans is far off, but they say their results have laid the critical groundwork to do so.
“Our experiments show that the architecture and function of our lab-made intestine strikingly resemble those of the healthy human gut, giving us real hope that our model could be used as the backbone for replacement intestine,” says principal investigator David Hackam, M.D., Ph.D., the Johns Hopkins Children’s Center’s surgeon-in-chief, who initiated and conducted most of the work at the University of Pittsburgh.
In an initial set of experiments reminiscent of a peanut butter-and-jelly sandwich technique, researchers took stem cells from the colons of babies undergoing intestinal surgeries and from mice, then added immune cells called macrophages, the body’s scavengers that seek out and engulf debris along with foreign and diseased cells. To this mix, they added cells called fibroblasts, whose function is to form collagen and other connective substances that bind tissues and organs together. The idea, the scientists say, was to create a mixture that closely mimics the natural composition of the gut.
“Intestinal cells do not grow and develop in a vacuum, so we sought to recreate the richness of the human gut, Hackam says. “We took the PB & J approach, adding a layer of stem cells on top of the scaffold, then topping them with a mixture of immune and collagen cells.”
Adding these components, they report, enhanced the growth of intestinal stem cells and differentiation into various mature cell types critical to the function of a healthy intestine. In comparison, stem cells grown in isolation without immune and connective cells in the mix grew more slowly and failed to differentiate well into multiple cell types.
In another set of experiments, researchers added probiotic bacteria to the newly created intestinal tissue. Doing so further amplified the growth and differentiation of new gut cells, specifically the growth of Paneth cells responsible for production of infection-fighting proteins that guard against intestinal infections, Hackam says, a finding that highlights the therapeutic potential of certain probiotics for NEC. Next, the team added bacteria-laden stool cells obtained from infants with NEC, but they observed a dramatic decrease in the number of intestinal cells called goblet cells, which are responsible for the production of protective mucus that coats and shields the intestine – a common occurrence in NEC. The observation, Hackam says, supports the notion that certain gut bacteria present in the colons of babies with NEC are responsible for sparking the rapid death of gut tissue that occurs in the condition.
Next, researchers implanted the newly created intestine into the bellies of mice. In a matter of days, the implanted intestine began producing new intestinal stem cells and stimulated the growth of new blood vessels around the implant. That observation, researchers say, affirmed the ability of the 3-D intestine to spur the growth of new tissue not only in lab dishes, but also in living organisms.
In a final step, the investigators implanted pieces of the newly created intestine – about 1.6 inches in length – into the lower portion of dog colons lacking parts of their intestinal lining. For two months, the dogs underwent periodic colonoscopies and intestinal biopsies. Strikingly, the guts of dogs with implanted intestines healed completely within eight weeks. By contrast, dogs that didn’t get intestinal implants experienced continued inflammation and scarring of their guts.
The Latest on: Regenerative medicine
via Google News
The Latest on: Regenerative medicine
- LifeNet Health opens regenerative medicine distribution center featuring orthopedic, neurosurgery productson October 16, 2019 at 10:11 am
1. LifeNet expects to distribute 700,000 tissue implants this year, for use in multiple specialties including orthopedics and neurosurgery. 2. The new 70,000-square-foot center aims to support the ...
- LifeNet Health establishes world's first dedicated regenerative medicine logistics and distribution center in Indianapolison October 15, 2019 at 5:08 pm
Oct. 15, 2019 /PRNewswire/ -- LifeNet Health, a global leader in regenerative medicine, today opened a technologically advanced logistics and distribution center in Indianapolis. This state-of-the-art ...
- BRIEF—Anglo-Japanese partnership in regenerative medicineon October 15, 2019 at 2:58 pm
The UK’s Biotechnology Association (BIA) and Japan’s Forum for Innovative Regenerative Medicine (FIRM) have agreed a collaboration. Their partnership is aimed at helping UK and Japanese companies in ...
- Global Regenerative Medicine Market Size and Forecast To 2026on October 15, 2019 at 4:28 am
Oct 15, 2019 (AmericaNewsHour) -- Regenerative Medicine Market Analysis According to Verified Market Research, the Global Regenerative Medicine Market was valued at USD 19.10 Billion in 2018 and is ...
- Global Regenerative Medicine Market to witness heavy growth prospects via manufacturing sector up to 2024on October 15, 2019 at 2:42 am
Oct 15, 2019 (Market Research Analyst via COMTEX) -- The report mainly studies the size, recent trends and development status of the Regenerative Medicine market, as well as investment opportunities, ...
- Regenerative Medicine Firm Recognized for Innovative Wound Care Biotechnologyon October 11, 2019 at 5:08 pm
Phoenix-based BioLab Sciences gains traction in regenerative medicine market, landing three national awards including Top 10 Wound Care Solution Provider BioLab Sciences, a regenerative biotechnology ...
- Medicine by Design to accelerate regenerative medicine discovery and translation with new $20-million investmenton October 11, 2019 at 11:52 am
... Shana Kelley of the Leslie Dan Faculty of Pharmacy are leading two of the teams that Medicine by Design is funding Medicine by Design is strengthening the University of Toronto as a global leader ...
- Medicine by Design to accelerate regenerative medicine discovery and translation withon October 11, 2019 at 11:43 am
Medicine by Design is strengthening the University of Toronto as a global leader in regenerative medicine with a new investment of as much as $20 million in research that will accelerate stem cell and ...
- Regenerative medicine group opens satellite clinic in North Mankatoon October 10, 2019 at 4:21 pm
Oliver, who has practiced regenerative medicine since 2007, said the procedures have shorter recovery times than full joint replacements. Patients are usually in and out of the appointment within a ...
- The World Market for 3D Bioprinting (2019-2024): Growing Demand for Regenerative Medicine & Stem Cell Research Presents Opportunitieson October 9, 2019 at 12:15 pm
The demand for research applications is further sub-segmented into drug research, regenerative medicine, and 3D cell culture. Among these, the drug research segment accounted for the largest share of ...
via Bing News